Related references
Note: Only part of the references are listed.撤稿声明: Can baseline endocrinological examination and thyroid ultrasound predict the development of thyroid disease in immunotherapy-treated patients? Results from a prospective, single-center, open-label study (Retraction of Vol 56, Pg 211, 2019)
Stefano Gay et al.
ENDOCRINE (2020)
Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis
Biagio Ricciuti et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Management of immune-related adverse events in endocrine organs induced by immune checkpoint inhibitors: clinical guidelines of the Japan Endocrine Society
Hiroshi Arima et al.
ENDOCRINE JOURNAL (2019)
A case of Graves' ophthalmopathy associated with pembrolizumab (Keytruda) therapy
Ella S. Y. Park et al.
JOURNAL OF AAPOS (2018)
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab
Koichi Sato et al.
LUNG CANCER (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center
Aaron Lisberg et al.
CANCER IMMUNOLOGY RESEARCH (2018)
A case of drug-induced Graves' Orbitopathy after combination therapy with Tremelimumab and Durvalumab
E. Sabini et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2018)
Acute management of the endocrine complications of checkpoint inhibitor therapy
C. E. Higham et al.
ENDOCRINE CONNECTIONS (2018)
Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small Cell Lung Cancer
Koji Haratani et al.
JAMA ONCOLOGY (2018)
Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab
Shiro Kimbara et al.
CANCER SCIENCE (2018)
Histology of Nivolumab-Induced Thyroiditis
Christina Neppl et al.
THYROID (2018)
Patients With Antithyroid Antibodies Are Prone To Develop Destructive Thyroiditis by Nivolumab: A Prospective Study
Tomoko Kobayashi et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2018)
Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer
J. C. Osorio et al.
ANNALS OF ONCOLOGY (2017)
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
A. M. Menzies et al.
ANNALS OF ONCOLOGY (2017)
Pembrolizumab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved Mechanisms
Danae A. Delivanis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
J. Bellmunt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Anti-PD-1 Antibody Therapy Induces Hashimoto's Disease with an Increase in Peripheral Blood Follicular Helper T Cells
Keiichi Torimoto et al.
THYROID (2017)
Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated With Pembrolizumab
Jeroen de Filette et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Immune Checkpoint Inhibitors: Review and Management of Endocrine Adverse Events
Elisa Gonzalez-Rodriguez et al.
ONCOLOGIST (2016)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ipilimumab-Induced Orbital Inflammation Resembling Graves Disease With Subsequent Development of Systemic Hyperthyroidism From CTLA-4 Receptor Suppression
Gary E. Borodic et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2014)
Drug-Induced Graves Disease From CTLA-4 Receptor Suppression
Gary Borodic et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2011)
The association between hypoechogenicity or irregular echo pattern at thyroid ultrasonography and thyroid function in the general population
Pernille Vejbjerg et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Thyroid ultrasonography as a tool for detecting thyroid autoimmune diseases and predicting thyroid dysfunction in apparently healthy subjects
T Rago et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2001)
Share Paper
